Targetable drug carriers: Present status and a future perspective - Introduction

被引：56

作者：

Yokoyama, M ^{[1
]}

Okano, T ^{[1
]}

机构：

[1] TOKYO WOMENS MED COLL,INST BIOMED ENGN,SHINJUKU KU,TOKYO 162,JAPAN

来源：

ADVANCED DRUG DELIVERY REVIEWS | 1996年 / 21卷 / 02期

关键词：

D O I：

10.1016/S0169-409X(96)00439-5

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：77 / 80

页数：4

共 16 条

[1]

CAMMAS S, IN PRESS J CONTR REL

[2]

GABIZON AA, 1992, CANCER RES, V52, P891

[3]

HUANG SK, 1994, CANCER RES, V54, P2186

[4]

KATAOKA K, 1993, J CONTROL RELEASE, V24, P119

[5] TARGETED CHEMOTHERAPY FOR UNRESECTABLE PRIMARY AND METASTATIC LIVER-CANCER [J].

KONNO, T ;

KAI, Y ;

YAMASHITA, R ;

NAGAMITSU, A ;

KIMURA, M .

ACTA ONCOLOGICA, 1994, 33 (02) :133-137

[6] ENHANCED TUMOR ACCUMULATION AND PROLONGED CIRCULATION TIMES OF MICELLE-FORMING POLY(ETHYLENE OXIDE-ASPARTATE) BLOCK COPOLYMER-ADRIAMYCIN CONJUGATES [J].

KWON, G ;

SUWA, S ;

YOKOYAMA, M ;

OKANO, T ;

SAKURAI, Y ;

KATAOKA, K .

JOURNAL OF CONTROLLED RELEASE, 1994, 29 (1-2) :17-23

[7] STERICALLY STABILIZED LIPOSOMES - A HYPOTHESIS ON THE MOLECULAR-ORIGIN OF THE EXTENDED CIRCULATION TIMES [J].

LASIC, DD ;

MARTIN, FJ ;

GABIZON, A ;

HUANG, SK ;

PAPAHADJOPOULOS, D .

BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1070 (01) :187-192

[8] CONJUGATES OF ANTICANCER AGENTS AND POLYMERS - ADVANTAGES OF MACROMOLECULAR THERAPEUTICS INVIVO [J].

MAEDA, H ;

SEYMOUR, LW ;

MIYAMOTO, Y .

BIOCONJUGATE CHEMISTRY, 1992, 3 (05) :351-362

[9]

MATSUMURA Y, 1986, CANCER RES, V46, P6387

[10]

OKANO T, 1994, JAPANESE TECHNOLOGY, V4

← 1 2 →